TABLE 4

Recommendations for the Use of Radionuclide Imaging in Patients With Heart Failure: Fundamental Assessment

IndicationTestClassLevel of Evidence
1. Initial assessment of LV and RV function at restRest RNAIA
2. Assessment of myocardial viability for consideration of revascularization in patients with CAD and LV systolic dysfunction who do not have anginaMPI (see Table 5), PETIB
3. Assessment of the copresence of CAD in patients without anginaMPIIIaB
4. Routine serial assessment of LV and RV function at restRest RNAIIbB
5. Initial or serial assessment of ventricular function with exerciseExercise RNAIIbB

CAD indicates coronary artery disease; LV, left ventricular; MPI, myocardial perfusion imaging; PET, positron emission tomography; RNA, radionuclide angiography.

  • National consensus treatment guidelines are directed by quantitative assessment of LVEF and identification of LVEF less than or equal to 40%.